A study by scientists at Sanford Burnham Prebys Medical Discovery Institute suggests that a protein called membralin is critical for keeping Alzheimer’s disease pathology in check and could provide a new path toward future treatments for Alzheimer’s disease. Read more.
Protein identified as critical for keeping Alzheimer’s disease pathology in check
Author(s): American Nurse Today
